News

Swiss drugmaker Roche said it plans to invest $50 billion in the U.S., the latest in a string of large companies boosting ...
Recursion Pharmaceuticals (RXRX) closed the latest trading day at $5.41, indicating a -1.64% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss ...